November 13. 2023 - Todd R. Golub, M.D., director and a founding core member of the Broad Institute of MIT and Harvard, presents the 2023 Jeffrey M. Trent Lecture in Cancer Research, "Perspectives on Cancer Precision Medicine."
Dr. Golub is a world leader in using genomics tools to understand the basis of cancer. He also pioneered the development of new cell-based approaches to drug discovery for cancer and other diseases. Golub is also the Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute and professor of pediatrics at Harvard Medical School. He is the recipient of multiple awards, including the Outstanding Achievement Award from the American Association for Cancer Research, the Paul Marks Prize for Cancer Research, and the Daland Prize from the American Philosophical Society. In 2014 he was elected to the National Academy of Medicine.
The National Human Genome Research Institute (NHGRI) established The Jeffrey M. Trent Lectureship in Cancer Research in 2003 in honor of its founding scientific director, who served in this role for more than nine years. His leadership and vision were instrumental in establishing NHGRI's Division of Intramural Research as one of the premier research programs in the world devoted to genetics and genomics. The annual Trent Lecture is given by a prominent cancer researcher who brings the kind of energy, creativity and enthusiasm to cancer research that Dr. Trent has exemplified throughout his career.
Learn more about the Jeffrey M. Trent Lectureship in Cancer Research: www.genome.gov...